These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 12614605)

  • 41. The interaction of illimaquinone, a selective inhibitor of the RNase H activity, with the reverse transcriptases of human immunodeficiency and murine leukemia retroviruses.
    Loya S; Hizi A
    J Biol Chem; 1993 May; 268(13):9323-8. PubMed ID: 7683648
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Structure/function studies of human immunodeficiency virus type 1 reverse transcriptase. Alanine scanning mutagenesis of an alpha-helix in the thumb subdomain.
    Beard WA; Stahl SJ; Kim HR; Bebenek K; Kumar A; Strub MP; Becerra SP; Kunkel TA; Wilson SH
    J Biol Chem; 1994 Nov; 269(45):28091-7. PubMed ID: 7525566
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Subunit-specific analysis of the human immunodeficiency virus type 1 reverse transcriptase in vivo.
    Mulky A; Sarafianos SG; Arnold E; Wu X; Kappes JC
    J Virol; 2004 Jul; 78(13):7089-96. PubMed ID: 15194785
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Major groove binding track residues of the connection subdomain of human immunodeficiency virus type 1 reverse transcriptase enhance cDNA synthesis at high temperatures.
    Matamoros T; Barrioluengo V; Abia D; Menéndez-Arias L
    Biochemistry; 2013 Dec; 52(51):9318-28. PubMed ID: 24303887
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Design, synthesis and antiviral evaluation of novel heteroarylcarbothioamide derivatives as dual inhibitors of HIV-1 reverse transcriptase-associated RNase H and RDDP functions.
    Corona A; Onnis V; Deplano A; Bianco G; Demurtas M; Distinto S; Cheng YC; Alcaro S; Esposito F; Tramontano E
    Pathog Dis; 2017 Aug; 75(6):. PubMed ID: 28859311
    [TBL] [Abstract][Full Text] [Related]  

  • 46. An enzymatically active chimeric HIV-1 reverse transcriptase (RT) with the RNase-H domain of murine leukemia virus RT exists as a monomer.
    Misra HS; Pandey PK; Pandey VN
    J Biol Chem; 1998 Apr; 273(16):9785-9. PubMed ID: 9545316
    [TBL] [Abstract][Full Text] [Related]  

  • 47. HIV-1 reverse transcriptase pausing at bulky 2' adducts is relieved by deletion of the RNase H domain.
    Patterson JT; Nickens DG; Burke DH
    RNA Biol; 2006 Oct; 3(4):163-9. PubMed ID: 17396357
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Virion instability of human immunodeficiency virus type 1 reverse transcriptase (RT) mutated in the protease cleavage site between RT p51 and the RT RNase H domain.
    Abram ME; Parniak MA
    J Virol; 2005 Sep; 79(18):11952-61. PubMed ID: 16140771
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Substituting a conserved residue of the ribonuclease H domain alters substrate hydrolysis by retroviral reverse transcriptase.
    Rausch JW; Le Grice SF
    J Biol Chem; 1997 Mar; 272(13):8602-10. PubMed ID: 9079691
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Mutations of the RNase H C helix of the Moloney murine leukemia virus reverse transcriptase reveal defects in polypurine tract recognition.
    Lim D; Orlova M; Goff SP
    J Virol; 2002 Aug; 76(16):8360-73. PubMed ID: 12134040
    [TBL] [Abstract][Full Text] [Related]  

  • 51. RNase H requirements for the second strand transfer reaction of human immunodeficiency virus type 1 reverse transcription.
    Smith CM; Smith JS; Roth MJ
    J Virol; 1999 Aug; 73(8):6573-81. PubMed ID: 10400754
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Mutations in human immunodeficiency virus type 1 RNase H primer grip enhance 3'-azido-3'-deoxythymidine resistance.
    Delviks-Frankenberry KA; Nikolenko GN; Barr R; Pathak VK
    J Virol; 2007 Jul; 81(13):6837-45. PubMed ID: 17428874
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effect of tRNA on the Maturation of HIV-1 Reverse Transcriptase.
    Ilina TV; Slack RL; Elder JH; Sarafianos SG; Parniak MA; Ishima R
    J Mol Biol; 2018 Jun; 430(13):1891-1900. PubMed ID: 29751015
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Construction of an enzymatically active ribonuclease H domain of human immunodeficiency virus type 1 reverse transcriptase.
    Stahl SJ; Kaufman JD; Vikić-Topić S; Crouch RJ; Wingfield PT
    Protein Eng; 1994 Sep; 7(9):1103-8. PubMed ID: 7530360
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Structural basis of asymmetry in the human immunodeficiency virus type 1 reverse transcriptase heterodimer.
    Wang J; Smerdon SJ; Jäger J; Kohlstaedt LA; Rice PA; Friedman JM; Steitz TA
    Proc Natl Acad Sci U S A; 1994 Jul; 91(15):7242-6. PubMed ID: 7518928
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Altering the RNase H primer grip of human immunodeficiency virus reverse transcriptase modifies cleavage specificity.
    Rausch JW; Lener D; Miller JT; Julias JG; Hughes SH; Le Grice SF
    Biochemistry; 2002 Apr; 41(15):4856-65. PubMed ID: 11939780
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Mutagenesis of human immunodeficiency virus reverse transcriptase p51 subunit defines residues contributing to vinylogous urea inhibition of ribonuclease H activity.
    Chung S; Miller JT; Johnson BC; Hughes SH; Le Grice SF
    J Biol Chem; 2012 Feb; 287(6):4066-75. PubMed ID: 22105069
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Characterization of the polymerase and RNase H activities of human foamy virus reverse transcriptase.
    Boyer PL; Stenbak CR; Clark PK; Linial ML; Hughes SH
    J Virol; 2004 Jun; 78(12):6112-21. PubMed ID: 15163704
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Template-primer binding affinity and RNase H cleavage specificity contribute to the strand transfer efficiency of HIV-1 reverse transcriptase.
    Luczkowiak J; Matamoros T; Menéndez-Arias L
    J Biol Chem; 2018 Aug; 293(35):13351-13363. PubMed ID: 29991591
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Replication of phenotypically mixed human immunodeficiency virus type 1 virions containing catalytically active and catalytically inactive reverse transcriptase.
    Julias JG; Ferris AL; Boyer PL; Hughes SH
    J Virol; 2001 Jul; 75(14):6537-46. PubMed ID: 11413321
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.